These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 12388617)

  • 1. Dopamine modulates the response of the human amygdala: a study in Parkinson's disease.
    Tessitore A; Hariri AR; Fera F; Smith WG; Chase TN; Hyde TM; Weinberger DR; Mattay VS
    J Neurosci; 2002 Oct; 22(20):9099-103. PubMed ID: 12388617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of dopamine and cognitive impairment on neural reactivity to facial emotion in Parkinson's disease.
    Dan R; Růžička F; Bezdicek O; Roth J; Růžička E; Vymazal J; Goelman G; Jech R
    Eur Neuropsychopharmacol; 2019 Nov; 29(11):1258-1272. PubMed ID: 31607424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oscillatory subthalamic nucleus activity is modulated by dopamine during emotional processing in Parkinson's disease.
    Huebl J; Spitzer B; Brücke C; Schönecker T; Kupsch A; Alesch F; Schneider GH; Kühn AA
    Cortex; 2014 Nov; 60():69-81. PubMed ID: 24713195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic system and dream recall: An MRI study in Parkinson's disease patients.
    De Gennaro L; Lanteri O; Piras F; Scarpelli S; Assogna F; Ferrara M; Caltagirone C; Spalletta G
    Hum Brain Mapp; 2016 Mar; 37(3):1136-47. PubMed ID: 26704150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition of emotions from visual and prosodic cues in Parkinson's disease.
    Ariatti A; Benuzzi F; Nichelli P
    Neurol Sci; 2008 Sep; 29(4):219-27. PubMed ID: 18810595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal functional connectivity of the amygdala is associated with depression in Parkinson's disease.
    Hu X; Song X; Yuan Y; Li E; Liu J; Liu W; Liu Y
    Mov Disord; 2015 Feb; 30(2):238-44. PubMed ID: 25545969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The amygdala of patients with Parkinson's disease is silent in response to fearful facial expressions.
    Yoshimura N; Kawamura M; Masaoka Y; Homma I
    Neuroscience; 2005; 131(2):523-34. PubMed ID: 15708493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Startling facts about emotion in Parkinson's disease: blunted reactivity to aversive stimuli.
    Bowers D; Miller K; Mikos A; Kirsch-Darrow L; Springer U; Fernandez H; Foote K; Okun M
    Brain; 2006 Dec; 129(Pt 12):3356-65. PubMed ID: 17095520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic modulation of cortical function in patients with Parkinson's disease.
    Mattay VS; Tessitore A; Callicott JH; Bertolino A; Goldberg TE; Chase TN; Hyde TM; Weinberger DR
    Ann Neurol; 2002 Feb; 51(2):156-64. PubMed ID: 11835371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine replacement therapy and deep brain stimulation of the subthalamic nuclei induce modulation of emotional processes at different spatial frequencies in Parkinson's disease.
    Mermillod M; Mondillon L; Rieu I; Devaux D; Chambres P; Auxiette C; Dalens H; Coulangeon LM; Jalenques I; Durif F
    J Parkinsons Dis; 2014; 4(1):97-110. PubMed ID: 24496100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopaminergic modulation of cognitive interference after pharmacological washout in Parkinson's disease.
    Fera F; Nicoletti G; Cerasa A; Romeo N; Gallo O; Gioia MC; Arabia G; Pugliese P; Zappia M; Quattrone A
    Brain Res Bull; 2007 Sep; 74(1-3):75-83. PubMed ID: 17683792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine-related dissociation of cortical and subcortical brain activations in cognitively unimpaired Parkinson's disease patients OFF and ON medications.
    Kim J; Zhang K; Cai W; YorkWilliams S; Ua Cruadhlaoich MAI; Llanes S; Menon V; Poston KL
    Neuropsychologia; 2018 Oct; 119():24-33. PubMed ID: 30040957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neural correlates of emotional valence processing in Parkinson's disease: dysfunction in the subcortex.
    Bell PT; Gilat M; Shine JM; McMahon KL; Lewis SJG; Copland DA
    Brain Imaging Behav; 2019 Feb; 13(1):189-199. PubMed ID: 28812218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroanatomical correlates of impaired decision-making and facial emotion recognition in early Parkinson's disease.
    Ibarretxe-Bilbao N; Junque C; Tolosa E; Marti MJ; Valldeoriola F; Bargallo N; Zarei M
    Eur J Neurosci; 2009 Sep; 30(6):1162-71. PubMed ID: 19735293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Automatic mood-congruent amygdala responses to masked facial expressions in major depression.
    Suslow T; Konrad C; Kugel H; Rumstadt D; Zwitserlood P; Schöning S; Ohrmann P; Bauer J; Pyka M; Kersting A; Arolt V; Heindel W; Dannlowski U
    Biol Psychiatry; 2010 Jan; 67(2):155-60. PubMed ID: 19748075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emotional processing in Parkinson's disease: a systematic review.
    Péron J; Dondaine T; Le Jeune F; Grandjean D; Vérin M
    Mov Disord; 2012 Feb; 27(2):186-99. PubMed ID: 22162004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dextroamphetamine modulates the response of the human amygdala.
    Hariri AR; Mattay VS; Tessitore A; Fera F; Smith WG; Weinberger DR
    Neuropsychopharmacology; 2002 Dec; 27(6):1036-40. PubMed ID: 12464460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic modulation of emotional memory in Parkinson's disease.
    Hälbig TD; Kopp UA; Wodarz F; Borod JC; Gracies JM; Ebersbach G; Kupsch A
    J Neural Transm (Vienna); 2008 Aug; 115(8):1159-63. PubMed ID: 18506391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of response times in early-stage Parkinson's disease during emotional processing of embodied and non-embodied stimuli.
    Botta A; Pelosin E; Lagravinese G; Marchese R; Di Biasio F; Bonassi G; Terranova S; Ravizzotti E; Putzolu M; Mezzarobba S; Cosentino C; Avenanti A; Avanzino L
    Sci Rep; 2024 Jun; 14(1):13031. PubMed ID: 38844758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine improves exploration after expectancy violations and induces psychotic-like experiences in patients with Parkinson's disease.
    Polner B; Moustafa AA; Nagy H; Takáts A; Győrfi O; Kéri S
    Neurosci Lett; 2016 Mar; 616():132-7. PubMed ID: 26820375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.